Pharmaceuticals

Kaiser Family Foundation Gives Stage to Opponents of Prop 61's Drug Pricing Reform

Submitted by Carmen Balber on Wed, 10/05/2016 - 17:37

What do supporters of drug price negotiation have to say when the pharmaceutical industry tries to shoot down drug pricing reforms?

You'd never know if you were watching Tuesday's webcast on prescription drugs and “Election-Cycle Proposals for Lowering Costs” hosted by the Kaiser Family Foundation (KFF) charity, which runs the nonprofit news service Kaiser Health News.

Tags: 

Capitol Watchdog: Upcoming Meetings to Watch

Submitted by Eddie Barrera on Wed, 01/06/2016 - 07:07

A few hearings next week might spark some interest. Assembly Health will be taking up Assemblyman David Chiu's timely AB 463, the Pharmaceutical Cost Transparency Act, which would require drug companies to reveal operational costs in order to better understand pricing for ultra-high-priced drugs.

Tags: 

Big Pharma Fattening Coffers to Stop Drug Price Reduction Initiative

Submitted by Eddie Barrera on Fri, 12/18/2015 - 14:03
Big Pharma fears only one thing: a government regulator who will push back on drug prices and protect consumers. Its fears could be realized in a year if an initiative intended to lower drug prices is approved by voters, which is why the drug companies have already filled a campaign war chest with nearly $40 million.
 

Tags: 

Capitol Watchdog is owned and operated by nonprofit Consumer Watchdog. For more information about Consumer Watchdog visit http://www.consumerwatchdog.org